Advertisements

Penicillin V STADA

Quick links to important sections

Penicillin V STADA

Medically reviewed

Rosario Oropesa

Last updated on 22/12/2025

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Advertisements

Overview of Penicillin V STADA

Quick Facts

Feature Detail
Drug Class Natural Penicillin Antibiotic
Active Ingredient Phenoxymethylpenicillin potassium (Penicillin V potassium)
Mechanism Inhibits bacterial cell wall synthesis
Administration Oral tablet or solution

Penicillin V STADA is a pharmaceutical product containing the active ingredient phenoxymethylpenicillin potassium, commonly known as penicillin V potassium or Penicillin VK. It belongs to the class of medications called natural penicillins, which are a subclass of beta-lactam antibiotics. This medication is prescribed to treat various mild to moderately severe bacterial infections caused by susceptible microorganisms, such as Streptococcus (which can cause strep throat or scarlet fever) and Pneumococcus species.

The drug functions by exerting a bactericidal action—it kills bacteria by interfering with the last stage of bacterial cell wall construction. Specifically, it inhibits the cross-linking of peptidoglycan, an essential polymer for the structural integrity of the bacterial cell wall. When the cell wall is compromised, the bacteria are unable to withstand internal pressure and eventually rupture and die. It is important to note that Penicillin V is an antibiotic and is therefore ineffective against viral infections, such as the common cold or flu, and should only be used to treat or prevent infections proven or strongly suspected to be caused by bacteria.

Penicillin V is advantageous for oral administration because it is more stable in stomach acid than Penicillin G, allowing it to be reliably absorbed through the gastrointestinal tract. It may also be used for prophylaxis (prevention) of certain conditions, such as recurrence of rheumatic fever.

Regulatory References

  1. Penicillin V Potassium Label (DailyMed)
Advertisements

What side effects are possible with Penicillin V STADA?

Official Safety Profile

The possible side effects and safety characteristics of Penicillin V STADA (phenoxymethylpenicillin potassium) are formally documented in regulatory prescribing information, classified primarily by frequency and the body system affected.

Adverse Reaction Categories

The most frequently reported adverse reactions are classified as Common in official labeling, primarily affecting the Gastrointestinal System. These often include nausea, vomiting, and diarrhea. Skin reactions such as rash, pruritus (itching), and urticaria (hives) are typically classified as Uncommon.

The most critical safety domain involves Immune System Disorders, covering the full spectrum of allergic reactions. While rare, Serious Adverse Reactions explicitly documented in regulatory sources include life-threatening conditions such as anaphylactic shock and angioedema, as well as severe systemic issues like pseudomembranous colitis, severe bullous skin reactions, and rare blood disorders (e.g., hemolytic anemia).

Safety Constraints and Populations

Regulatory documents define a critical constraint: Penicillin V is absolutely contraindicated in individuals with a known severe hypersensitivity (allergy) to penicillin or other beta-lactam antibiotics. Furthermore, specific safety notes apply to certain populations. For patients with renal impairment, there is an officially documented risk of neurotoxicity, potentially leading to seizures, which is generally associated with very high doses or reduced drug clearance. Hypersensitivity reactions may also occur at the start of treatment and sometimes after the first dose. This official safety framework guides the understanding of the medicine's risk profile without providing therapeutic advice.

Advertisements

Overdose and Emergency Response

Overdose and When to Seek Help

This section reflects the documented descriptions of overdosage for Phenoxymethylpenicillin potassium (Penicillin V potassium) as stated in official government regulatory documents.

Overdose Presentation Official Regulatory Statement
Acute Manifestations Nausea, vomiting, diarrhoea, and abdominal pain are the primary documented gastrointestinal symptoms.
Severe Symptoms The potential for Central Nervous System (CNS) toxicity, including major motor seizures (convulsions), is documented, associated with very high dose exposure.
Population Risk Patients with renal insufficiency are noted to be at increased risk for CNS toxicity and a serious electrolyte imbalance, hyperkalaemia, following overdosage.

Emergency Action Requirements

In the event of a suspected overdose, immediate medical attention is required, including calling a Poison Control helpline. Emergency services must be contacted immediately if severe, life-threatening symptoms occur, such as collapse, trouble breathing, unresponsiveness, or a seizure.

Management and Antidote Status

Management should consist of symptomatic and supportive therapy. Official labeling explicitly states that no specific antidote is known for Penicillin V potassium overdose. The drug can be removed from the system by haemodialysis, a procedure noted in regulatory documents.


This information defines the official overdose profile by documenting expected gastrointestinal effects and the potential for serious CNS and electrolyte complications, which are magnified in renal impairment. These factors dictate the urgent requirement to contact emergency services immediately for severe symptoms such as collapse or seizures, exactly as mandated by regulatory authorities.

Advertisements

Therapeutic Uses of Penicillin V STADA

Quick Facts: Uses of Penicillin V STADA

  • Supports the management of mild to moderately severe upper respiratory tract infections.
  • Assists in addressing certain skin and soft tissue infections.
  • Used for the care of mild erysipelas and scarlet fever caused by susceptible organisms.
  • Contributes to the prophylaxis of recurrent rheumatic fever.
  • May be prescribed for specific infections of the oropharynx (e.g., Vincent's gingivitis).

Penicillin V STADA is a prescription medication utilized in the health management of infections caused by certain types of bacteria sensitive to Penicillin. The primary therapeutic function of this medicine is to support the resolution of mild to moderately severe infections.

Key areas where Penicillin V is clinically established include the care of upper respiratory tract concerns, such as strep throat, mild pneumonia, and ear infections (otitis media). The medication also plays a role in addressing certain skin and soft tissue infections and is an option for the treatment of scarlet fever and erysipelas caused by susceptible organisms.

Furthermore, Penicillin V STADA contributes to an ongoing strategy to prevent the recurrence of rheumatic fever. It is also prescribed to reduce the likelihood of pneumococcal infection in individuals with certain medical considerations like asplenia or sickle cell disease.

It is important to note that this medicine is intended to act against bacterial infections and does not offer benefit against viral conditions, such as the common cold or flu. Treatment should always be guided by clinical assessment and susceptibility testing.

Advertisements

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Penicillin V STADA — Official Regulatory Information

Eligibility Scope

Category Eligibility Rule (Strictly Label-Based)
Populations for whom use is allowed Adults, older adults, and pediatric patients (children and infants, typically ge 1 year) for mild to moderately severe infections.
Populations for whom use is contraindicated Patients with a known hypersensitivity reaction (allergy) to any penicillin or any of the product’s components.
Condition-specific eligibility rules Severe Renal Impairment: Requires conditional use, typically involving dosage modification due to delayed excretion. Severe Illness: The oral route is not recommended for severe, systemic infections or for patients with severe gastrointestinal issues (e.g., persistent vomiting) that prevent reliable absorption.
Pregnancy and lactation eligibility status Pregnancy: Generally permitted (extensive clinical use documented). Lactation: Breastfeeding is not contraindicated, as only trace amounts of the drug are detected in breast milk.

Eligibility Classifications (High-Level)

Category Classification as Defined in Official Documents
Eligibility Severity Classification Contraindication (Absolute exclusion) and Restricted/Conditional Use (Requires caution or modification).
Regulatory Basis EMA SmPC and FDA Prescribing Information.

Resulting Eligibility Structure

Official eligibility statements:

  • Contraindicated in patients with a history of penicillin allergy.
  • Should not be used to treat severe acute infections, such as meningitis or bacteremia.
  • Use is restricted in patients with severe renal impairment, requiring careful consideration.
  • Generally permitted for use across all established age groups and during pregnancy/lactation.

Connection to the overall eligibility profile: Official regulatory documents establish patient eligibility by imposing an absolute exclusion for penicillin allergy and restricting the oral form’s use in severe, systemic infections or when poor gastrointestinal absorption is expected. Use is conditional on normal physiological function, particularly in cases of renal impairment.

Advertisements

What should I know about interactions with other medicines?

Interactions with other medicines and products

This section outlines the officially documented interaction patterns for Penicillin V STADA (phenoxymethylpenicillin potassium) as stated in government regulatory sources, focusing strictly on how co-administered substances modify the drug's exposure or action.


Pharmacokinetic and Pharmacodynamic Interactions

The most significant interactions involve changes to the body's handling of the medicine (pharmacokinetics) and effects on its antibacterial activity (pharmacodynamics).

Interacting Substance/Category Official Interaction Description
Probenecid Inhibits the renal tubular secretion of phenoxymethylpenicillin, leading to increased and prolonged plasma concentrations of penicillin V.
Methotrexate Phenoxymethylpenicillin decreases the renal clearance of methotrexate, resulting in increased plasma concentrations and heightened risk of methotrexate toxicity.
Bacteriostatic Antibiotics (e.g., Tetracyclines) May result in antagonism or reduction of the bactericidal effect of penicillin V.
Food Reduces the rate and extent of oral absorption of phenoxymethylpenicillin.

Regulatory Context and Restrictions

Official regulatory documents establish these interaction effects. The interaction with Probenecid is a documented pharmacokinetic interaction due to renal clearance competition. The constraint concerning food is also a documented pharmacokinetic interaction affecting oral bioavailability. No combinations are formally listed as contraindicated based solely on drug-drug interaction risk in standard regulatory documents.

Advertisements

Mechanism of Action

How Penicillin V STADA Works

Penicillin V STADA is a beta-lactam antibiotic that acts by targeting the unique structural processes of susceptible bacteria. Its mechanism centers on binding to Penicillin-Binding Proteins (PBPs), a class of bacterial transpeptidases and carboxypeptidases essential for cell wall assembly. The drug acts as a suicide substrate, forming a stable, covalent bond within the active site of the PBP enzymes.

This specific molecular interaction blocks the transpeptidation reaction, which prevents the necessary cross-linking of peptidoglycan chains that form the rigid bacterial cell wall. The interruption of this key molecular pathway results in a defective, structurally unsound cell wall. The compromised wall is subsequently unable to withstand the microorganism's high internal osmotic pressure, leading directly to rapid cell rupture and dissolution (lysis). This sequence results in cellular death within the targeted microorganisms.

Advertisements

Dosage and Administration Information

Instruction Map: How to use Penicillin V STADA — Administration Guidelines

Administration Scope

Instruction Detail
Route of administration: Oral administration only.
Dosing schedule: Treatment doses typically range from 250 mg to 500 mg. The usual dose for long-term prophylaxis of rheumatic fever is 250 mg daily or twice daily. The dose is calculated based on age or weight for pediatric patients.
Timing in relation to meals (if applicable): Each dose must be taken with water at least 30 minutes before food or 2 hours after food to optimize absorption.
Preparation requirements (if applicable): Powder for oral solution requires reconstitution according to specific package directions prior to use.
Age-group administration rules: The dosage for older adults is generally the same as the standard adult regimen, but dose reduction is required if renal function is markedly impaired.
Missed-dose rules: The missed dose should be taken as soon as remembered, unless it is nearly time for the next scheduled dose, in which case the missed dose is typically omitted to maintain the regular schedule.
Special procedural conditions: Oral therapy must not be relied upon in severe illness or conditions that inhibit proper gut absorption, such as severe vomiting. The full course of therapy must be completed exactly as prescribed.

Instruction Classifications (High-Level)

Classification Detail
Administration method type: Oral (Tablets or Oral Solution).
Frequency pattern: Multiple daily doses (e.g., every six hours for treatment) and Twice daily (for prophylaxis).
Use-context constraints: Constraints are tied to absorption optimization (fasting state) and organ function (renal impairment).

Resulting Procedural Structure

Step sequence:

  • Take the prescribed amount (tablet or reconstituted oral solution) with water.
  • Ensure the intake occurs at least 30 minutes before or 2 hours after a meal.
  • Administer the dose according to the prescribed frequency (e.g., every six hours).
  • Continue the medicine for the full duration, specifically a 10-day minimum for streptococcal infections.
  • Complete the full course of therapy exactly as directed.

Connection to the overall use protocol (2–4 sentences): The use protocol is focused on optimizing drug absorption and maintaining adequate systemic levels. This protocol specifies the necessity of oral administration in a fasting state and mandates strict adherence to the prescribed frequency and duration to ensure proper procedural use. Dosage modifications are required only when specific physiological conditions, such as marked renal impairment, are present.

Advertisements

Recent Clinical Evidence

Research Evidence / Overview of Studies for Penicillin V STADA


Evidence for Use in Acute Bacterial Infections

Research has examined Penicillin V in the context of specific infections of the throat and upper respiratory system, such as tonsillitis and strep throat. Studies conducted during periods of increased symptom activity include systematic reviews and randomized controlled trials (RCTs). These trials were used in research exploring short-term symptom changes and monitored patient status over defined time intervals, often a week to ten days.

The studies explored measurements related to symptom changes and monitored patient-reported outcomes describing perceived experience and the overall duration of symptoms. Findings describe patterns observed in the studies related to measured patient status in the observed populations, and research highlights measurements taken during the short study period.


Evidence for Prophylactic (Preventive) Use

Penicillin V was studied for its use in exploring measurements related to the incidence of rheumatic fever recurrence and exploring measurements related to the incidence of serious pneumococcal infections in high-risk groups. For the incidence of rheumatic fever recurrence, the evidence is largely based on foundational historical studies and established clinical consensus.

For the incidence of pneumococcal infections, particularly in infants and young children with conditions like sickle cell disease, research examined measurements of serious infection rates. Studies monitored these groups over several years of early childhood. Data show patterns related to infection rates in these specific populations.


Evidence Gaps and Areas of Uncertainty

Evidence highlights what is known—and what is still uncertain—about Penicillin V. One key limitation is that evidence quality varies across studies, with some data drawn from older trials and observational settings. For most acute indications, follow-up durations were limited. Studies exploring direct comparison with other regimens are limited, and subgroup findings are uncertain for populations outside of the primary study groups (e.g., older adults with extensive comorbidities). Research provides context but not individual predictions.

Advertisements

Frequently Asked Questions (FAQ)

Common questions about Penicillin V STADA (FAQ)


Q: How quickly does Penicillin V STADA usually start working?

A: Penicillin V is described in official documents as being a bactericidal medicine, meaning it works by directly killing the susceptible bacteria. The drug is understood to begin its action quickly at a molecular level, but the timeframe for a patient to perceive symptomatic relief can vary.


Q: Can Penicillin V STADA cause stomach issues or nausea?

A: Official documentation classifies gastrointestinal disturbances as common expected side effects of this medicine. These effects frequently include feelings of nausea and vomiting. Official sources classify these as common, and the product information describes these potential reactions.


Q: Does Penicillin V STADA affect the effectiveness of birth control pills?

A: Official information from regulatory documents states that the simultaneous administration with oral contraceptives can potentially cause the hormonal contraception to lose its efficacy. Due to this reported risk, official patient information often states that additional forms of contraceptive precautions may be considered.


Q: What types of bacteria is Penicillin V STADA effective against?

A: The drug is described in official sources as being active against certain types of bacteria, primarily Gram-positive bacteria. This includes various Streptococcus species and Pneumococci. The medicine is prescribed for use in infections where the specific microorganism is known or strongly suspected to be susceptible to penicillin.


Q: Does Penicillin V STADA have any known interactions with alcohol?

A: Official patient information generally indicates that alcohol does not directly interfere with how the penicillin V medicine works in the body. However, patient materials note that consuming alcohol may potentially worsen certain common side effects of the drug, such as stomach upset, according to official patient information.


Q: Can Penicillin V STADA cause diarrhea?

A: Official regulatory documents list diarrhoea as a common expected side effect associated with the use of Penicillin V. Antibiotics can sometimes disturb the natural balance of bacteria in the gut, which can lead to this gastrointestinal effect.


Q: Does Penicillin V STADA interact with blood thinners like warfarin?

A: Official regulatory documents indicate that penicillins may interfere with anticoagulant control. Specifically, the drug has been noted to potentially increase the anticoagulant activities of certain agents, such as warfarin. Regulatory documents indicate that this interference may require clinical consideration.


Q: Can Penicillin V STADA be used to prevent infections?

A: Yes, official indications for the drug include its use for prophylaxis (prevention) in specific situations. This preventive use is primarily documented for conditions such as the recurrence of rheumatic fever and certain pneumococcal infections in high-risk patient groups.


Q: Is Penicillin V STADA the same as just 'Penicillin'?

A: Penicillin is a broad class of antibiotics. Penicillin V is the phenoxymethyl analog of the original penicillin (Penicillin G), meaning it is a specific type within that class. It is distinguished as the form that is stable enough in stomach acid to be absorbed reliably when taken by mouth.


Q: Are there any common foods or drinks that should be avoided with Penicillin V STADA?

A: Official documents do not specify individual common foods or drinks to avoid. However, they strictly state that the medicine should be taken on an empty stomach (e.g., at least 30 minutes before or 2 hours after a meal). It is stated that food reduces the oral absorption of the medicine, which is why it should be taken on an empty stomach.


Q: Why do some people need to take Penicillin V STADA for a longer time than others?

A: The required duration of use is defined in official documents by the reason for use. Treatment courses for acute infections often have a set minimum duration. This differs from the often longer-term use required when the medicine is prescribed for prophylaxis (prevention) of conditions like rheumatic fever.


Q: Is Penicillin V STADA safe for children, based on official information?

A: Yes, the official regulatory documents include specific dosage recommendations for pediatric patients across various age groups, including infants and older children. This indicates that the medicine is approved for use across the established age groups, with specific dosage guidelines provided in the official documentation.


Q: Can taking Penicillin V STADA cause a yeast infection?

A: The use of any antibiotic can sometimes lead to an overgrowth of non-susceptible organisms, including fungi. Official patient information notes that this may manifest as conditions like oral thrush or other fungal infections. This is a potential secondary effect noted in patient information related to antibiotic use.


Q: Can older adults safely use Penicillin V STADA, based on regulatory data?

A: The official dosage for older adults is generally the same as the standard adult dose. However, the regulatory instructions require that the dosage should be reduced if a patient’s kidney function is markedly impaired, due to the potential for delayed excretion, which is noted in regulatory instructions.


Q: What should I do if I accidentally take too much Penicillin V STADA?

A: In cases where more than the prescribed amount is accidentally taken, official patient information generally states that contacting a healthcare provider or poison control center is appropriate. Overdose effects may involve an increase in common effects like nausea, vomiting, or diarrhea, and may, in rare cases, lead to more severe reactions.


Q: Is it possible to build up a resistance to Penicillin V STADA over time?

A: Official prescribing information states that the medicine is only indicated for infections caused by organisms whose susceptibility to penicillin is confirmed. This regulatory guidance acknowledges bacterial resistance as a clinical factor that affects the effectiveness of antibiotics.


Q: What are the general rules regarding driving or operating machinery while on Penicillin V STADA?

A: Official regulatory documents typically state that the medicine is not normally expected to affect the ability to drive or operate heavy machinery. Official documents note that caution may be warranted if a patient experiences any side effects that could impair concentration.


Q: Why is the full name of the drug Penicillin V Potassium STADA?

A: The active ingredient's full chemical name is phenoxymethylpenicillin potassium. Official documents explain that the addition of potassium makes it the potassium salt of penicillin V. This specific form is used to ensure the medicine can be formulated into effective tablets or a stable solution.


Q: How is Penicillin V STADA different from Penicillin G?

A: Penicillin V is described in official sources as being a more acid-stable version compared to Penicillin G. It resists inactivation by the acid in the stomach better than Penicillin G, which is primarily used in other forms of administration.


Q: What is the evidence base for using Penicillin V STADA for skin infections?

A: Official indications for the drug include the treatment of mild infections of the skin and soft tissues. This includes certain conditions like erysipelas and specific staphylococcal infections that are known to be sensitive to the action of penicillin.


Q: Does the efficacy of Penicillin V STADA change if I have a cold or flu?

A: Official regulatory information emphasizes that the drug is an antibiotic and is only effective against bacterial infections. The medicine is not for use in treating viral infections, such as the common cold or flu.


Q: What is the typical timeframe for a skin rash to appear if someone is allergic to Penicillin V STADA?

A: Official warnings state that hypersensitivity reactions (allergic reactions) may occur at the start of treatment and sometimes even after the first dose. According to official sources, reactions are documented as potentially occurring at the start of treatment or sometimes after the first dose.


Q: Are there any major drug classes that interact with Penicillin V STADA?

A: Official regulatory documents specifically mention interactions that can occur with certain drug classes. These include bacteriostatic antibiotics (such as tetracyclines), which may reduce its effectiveness, and drugs like Probenecid (used for gout), which can affect the kidney’s ability to clear Penicillin V.


Q: Does Penicillin V STADA contain lactose or any common allergens?

A: The official product documentation states that certain forms of the medicine, such as the tablets, contain lactose as an excipient. The liquid oral solution may contain other excipients like sucrose or sorbitol. Patients with specific sensitivities often review the ingredient list, which is available in the official documentation.


Q: What are the key points to discuss with a healthcare provider about Penicillin V STADA?

A: Official warnings suggest that important factors for discussion include any known history of allergies to penicillins or related antibiotics. Discussion points also include the presence of any existing kidney impairment or any severe gastrointestinal issues like persistent vomiting that could affect the absorption of the oral medicine.


Q: What is the role of Penicillin V STADA in managing dental infections?

A: Official indications for the drug include the treatment of certain infections of the oropharynx (the middle part of the throat), such as Fusospirochaetosis (a type of acute ulcerative gingivitis). These are infections commonly managed with oral penicillin.

Advertisements

How should Penicillin V STADA be stored and disposed of?

How to Store and Dispose of Penicillin V STADA

Storage requirements for Penicillin V STADA (phenoxymethylpenicillin potassium) vary based on the product form. All forms must be kept out of the reach and sight of children.


Storage Conditions

Product Form Storage Temperature Stability Constraint
Tablets / Unreconstituted Powder Store below 25°C Protect from moisture and keep in original container
Reconstituted Liquid Suspension Store refrigerated at 2°C to 8°C Do not freeze; discard after 14 days

Disposal

Unused or expired Penicillin V STADA must not be disposed of in household waste or poured down the sink or toilet (wastewater). Disposal must follow local regulations or collection programs, such as returning the product to a pharmacy.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Penicillin V STADA found in:

A-Z Index: